HIGD1AP10: A Potential Drug Target and Biomarker (G100287960)

Target Name: HIGD1AP10

NCBI ID: G100287960

HIGD1AP10

Other Name(s): HIG1 hypoxia inducible domain family member 1A pseudogene 10

HIGD1AP10: A Potential Drug Target and Biomarker

HIGD1AP10, also known as heat shock protein 1.2 (HSP1.2), is a protein that is expressed in various tissues and cells, including the brain, heart, liver, and muscle. It is a heat shock protein, which means that it is produced in response to increased temperatures, such as those that occur during exercise or other physical activities.

HIGD1AP10 has been identified as a potential drug target due to its involvement in a number of cellular processes that are associated with aging and a variety of diseases, including neurodegenerative disorders, cancer, and cardiovascular disease.

One of the key functions of HIGD1AP10 is its role in the regulation of cellular stress responses. During times of stress, such as exercise or inflammation, HIGD1AP10 helps to protect cells from damage by allowing them to survive and recover more quickly.

In addition to its role in stress response, HIGD1AP10 is also involved in the regulation of cell growth and differentiation. It has been shown to play a role in the development and maintenance of cancer cells, as well as in the regulation of cellular processes that are associated with aging.

HIGD1AP10 has also been shown to be involved in the regulation of pain perception and neurotransmitter release. It has been shown to play a role in the regulation of pain sensitivity, as well as in the production of neurotransmitters that are involved in pain signaling.

Given its involvement in a variety of cellular processes, HIGD1AP10 is a promising candidate for drug targeting. Studies have shown that HIGD1AP10 can be effectively targeted with small molecules, such as those that inhibit its activity as a protein or that interact with it in a specific way.

In addition to its potential as a drug target, HIGD1AP10 is also a potential biomarker. The production of HIGD1AP10 is regulated by a variety of factors, including temperature and stress. This makes it a potential indicator of the overall health and function of cells, as well as a potential target for therapies that are aimed at preventing or treating a variety of diseases.

Overall, HIGD1AP10 is a protein that has the potential to be a drug target and biomarker, due to its involvement in a variety of cellular processes that are associated with aging and a variety of diseases. Further research is needed to fully understand its role and potential as a therapeutic target.

Protein Name: HIG1 Hypoxia Inducible Domain Family Member 1A Pseudogene 10

The "HIGD1AP10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HIGD1AP10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets